Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDC: NECC compounding crisis could have been worse

This article was originally published in Scrip

Executive Summary

The fungal meningitis outbreak that struck the US in 2012-13 linked to tainted methylprednisolone acetate compounded by a Massachusetts pharmacy – sickening 751 people in 20 states across the US, killing 64 – could have been much worse, with the potential for many more Americans to be dead or ill had it not been for the rapid response to the crisis, researchers from the Centers for Disease Control and Prevention (CDC) said in a new analysis.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC028744

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel